- Home
- XBIT vs RILY Comparison
XBIT vs RILY Comparison
Compare XBIT & RILY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIT
- RILY
- Stock Information
- Founded
- XBIT 2005
- RILY 1973
- Country
- XBIT United States
- RILY United States
- Employees
- XBIT N/A
- RILY N/A
- Industry
- XBIT Pharmaceuticals and Biotechnology
- RILY Investment Managers
- Sector
- XBIT Health Care
- RILY Finance
- Exchange
- XBIT Nasdaq
- RILY Nasdaq
- Market Cap
- XBIT 89.6M
- RILY 91.8M
- IPO Year
- XBIT 2015
- RILY 2007
- Fundamental
- Price
- XBIT $2.50
- RILY $2.94
- Analyst Decision
- XBIT
- RILY
- Analyst Count
- XBIT 0
- RILY 0
- Target Price
- XBIT N/A
- RILY N/A
- AVG Volume (30 Days)
- XBIT 52.8K
- RILY 727.6K
- Earning Date
- XBIT 08-11-2025
- RILY 08-14-2025
- Dividend Yield
- XBIT N/A
- RILY N/A
- EPS Growth
- XBIT N/A
- RILY N/A
- EPS
- XBIT N/A
- RILY N/A
- Revenue
- XBIT N/A
- RILY $854,383,000.00
- Revenue This Year
- XBIT N/A
- RILY N/A
- Revenue Next Year
- XBIT N/A
- RILY N/A
- P/E Ratio
- XBIT N/A
- RILY N/A
- Revenue Growth
- XBIT N/A
- RILY N/A
- 52 Week Low
- XBIT $2.50
- RILY $2.67
- 52 Week High
- XBIT $8.32
- RILY $21.18
- Technical
- Relative Strength Index (RSI)
- XBIT 33.01
- RILY 42.38
- Support Level
- XBIT $2.57
- RILY $2.79
- Resistance Level
- XBIT $2.78
- RILY $3.34
- Average True Range (ATR)
- XBIT 0.14
- RILY 0.17
- MACD
- XBIT -0.03
- RILY -0.01
- Stochastic Oscillator
- XBIT 0.00
- RILY 22.73
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
About RILY B. Riley Financial Inc.
B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.